Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts.
Clin Gastroenterol Hepatol. 2018 Nov;16(11):1832-1833. doi: 10.1016/j.cgh.2017.10.031. Epub 2017 Nov 16.
Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile infection (rCDI), with cure rates higher than 80%. FMT failure is defined as diarrhea and a positive stool laboratory test for C difficile at any point during the 8-week follow-up period after FMT..
粪便微生物群移植(FMT)是治疗复发性艰难梭菌感染(rCDI)的有效方法,治愈率高于 80%。FMT 失败的定义为在 FMT 后 8 周的随访期间的任何时间出现腹泻和粪便艰难梭菌实验室检测阳性。